Nautilus Biotechnology Inc (NAUT)
2.63
+0.06
(+2.33%)
USD |
NASDAQ |
Nov 05, 11:23
Nautilus Biotechnology Price to Book Value: 1.478 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.444 |
| November 01, 2024 | 1.467 |
| October 31, 2024 | 1.461 |
| October 30, 2024 | 1.489 |
| October 29, 2024 | 1.557 |
| October 28, 2024 | 1.579 |
| October 25, 2024 | 1.512 |
| October 24, 2024 | 1.529 |
| October 23, 2024 | 1.545 |
| October 22, 2024 | 1.562 |
| October 21, 2024 | 1.557 |
| October 18, 2024 | 1.658 |
| October 17, 2024 | 1.613 |
| October 16, 2024 | 1.663 |
| October 15, 2024 | 1.596 |
| October 14, 2024 | 1.585 |
| October 11, 2024 | 1.607 |
| October 10, 2024 | 1.523 |
| October 09, 2024 | 1.568 |
| October 08, 2024 | 1.512 |
| October 07, 2024 | 1.495 |
| October 04, 2024 | 1.523 |
| October 03, 2024 | 1.478 |
| October 02, 2024 | 1.534 |
| October 01, 2024 | 1.517 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.602 |
| September 27, 2024 | 1.551 |
| September 26, 2024 | 1.519 |
| September 25, 2024 | 1.503 |
| September 24, 2024 | 1.610 |
| September 23, 2024 | 1.484 |
| September 20, 2024 | 1.642 |
| September 19, 2024 | 1.599 |
| September 18, 2024 | 1.530 |
| September 17, 2024 | 1.548 |
| September 16, 2024 | 1.578 |
| September 13, 2024 | 1.546 |
| September 12, 2024 | 1.455 |
| September 11, 2024 | 1.466 |
| September 10, 2024 | 1.503 |
| September 09, 2024 | 1.418 |
| September 06, 2024 | 1.359 |
| September 05, 2024 | 1.370 |
| September 04, 2024 | 1.322 |
| September 03, 2024 | 1.354 |
| August 30, 2024 | 1.386 |
| August 29, 2024 | 1.375 |
| August 28, 2024 | 1.396 |
| August 27, 2024 | 1.407 |
| August 26, 2024 | 1.407 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5942
Minimum
Dec 16 2022
3.213
Maximum
Jun 30 2021
1.352
Average
1.325
Median
Price to Book Value Benchmarks
| Incyte Corp | 4.666 |
| Merck & Co Inc | 5.903 |
| Neogen Corp | 1.011 |
| Pfizer Inc | 1.796 |
| Repligen Corp | 4.013 |
Price to Book Value Related Metrics
| Price | 2.63 |
| Earnings Yield | -21.29% |
| Market Cap | 330.23M |